Arvee Laboratories (India) Limited has informed the Exchange regarding Resignation of Mr Shalin Bharaybhai Choksi as Whole Time Director of the company w.e.f. Jun 30, 2025.
ARVEE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arvee Laboratories has informed the NSE that Mr. Shalin Bharatbhai Chokshi (DIN: 00191903) has resigned from the post of Whole Time Director with effect from close of business hours on June 30, 2025. The reason cited in his resignation letter is prevailing health conditions, specifically stress and anxiety, which he wishes to prioritize going forward. Mr. Chokshi held no shares in the company at the time of resignation. The intimation to the stock exchange was made on August 1, 2025, about a month after the effective date. A Company Secretary signed the disclosure.
This is a key managerial personnel exit due to personal health reasons, not governance concerns, so the near-term impact is likely limited. However, shareholders should watch for any announcement on a replacement, as the absence of a Whole Time Director could affect day-to-day operations and decision-making at this small-cap pharma company.